Title : Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.

Pub. Date : 2012 Feb

PMID : 21831476






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since 1992 we used a combination of epirubicin and ifosfamide (EI) as a non-cross-resistant regimen in relapsed or refractory SCLC. Epirubicin SCLC1 Homo sapiens